Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1994-12-21
|
pubmed:abstractText |
Cardiac function was measured in 16 prepubertal Ecuadorean patients with growth hormone receptor deficiency given insulin-like growth factor I (IGF-I) during part of a clinical trial. The IGF-I was given subcutaneously twice daily at a dose of 40 micrograms/kg on days 1 and 2, 80 micrograms/kg on days 3 and 4, and 120 micrograms/kg thereafter. Heart rate was determined at baseline (pretreatment) and on days 1-7 by repeated palpation of the radial artery and at baseline and on days 2, 4 and 7 by continuous portable Holter monitoring. Heart rate measured by both methods rose progressively with increasing doses of IGF-I. The mean palpated pulse exceeded baseline on each treatment day and was significantly higher on day 5 than day 4 and significantly higher on day 3 than day 2. The mean Holter heart rate was significantly higher on day 4 than on day 2 and significantly higher on day 2 than at baseline. Non-significant glucose and electrolyte changes did not appear to be associated with the cardiac events.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0803-5326
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
399
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
137-9
|
pubmed:dateRevised |
2008-5-12
|
pubmed:meshHeading |
pubmed-meshheading:7949599-Adolescent,
pubmed-meshheading:7949599-Child,
pubmed-meshheading:7949599-Child, Preschool,
pubmed-meshheading:7949599-Female,
pubmed-meshheading:7949599-Heart Rate,
pubmed-meshheading:7949599-Humans,
pubmed-meshheading:7949599-Insulin-Like Growth Factor I,
pubmed-meshheading:7949599-Male,
pubmed-meshheading:7949599-Receptors, Somatotropin,
pubmed-meshheading:7949599-Recombinant Proteins
|
pubmed:year |
1994
|
pubmed:articleTitle |
Heart rate increases in patients with growth hormone receptor deficiency treated with insulin-like growth factor I.
|
pubmed:affiliation |
Institute of Endocrinology, Metabolism and Reproduction IEMIR, Quito, Ecuador.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|